Facebook
Twitter
LinkedIn

Media Center

FAST, Fellows and CARB-X Update October 2019
Facebook
Twitter
LinkedIn

FAST & Fellows Round-Up

  • Fauna Bio (FAST Spring ’19) was awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) for the development of its integrated genomics platform and testing of repurposed drug candidates Read More
  • Atropos Therapeutics (FAST Spring ’18) and Atomwise launched a joint venture to discover and advance a pipeline of compounds for promising discovery targets using senescence assay and AI technologies for the treatment of cancer Read More
  • Eidos Therapeutics (FAST Spring ’16) and Alexion Pharmaceuticals announced an agreement to grant Alexion an exclusive license to develop and commercialize AG10 for transthyretin amyloidosis (ATTR) in Japan Read More
  • Magnetic Insight (FAST Spring ‘15) introduced the first commercially available magnetic particle imaging (MPI) system with integrated X-ray computed tomography (CT) Read More

CARB-X News

  • CARB-X funds SutroVax to develop a new vaccine to prevent Group A Streptococcal infections Read More
  • CARB-X strengthens leadership team with appointment of Erin Duffy as Chief of Research and Development (R&D) Read More
  • 2018-19 Annual Report: Progress in CARB-X’s fight against drug-resistant bacteria with new funding, expertise and strategic focus Read More
  • CARB-X funds Procarta Biosystems to develop oligonucleotide-based antibiotics to combat life-threatening Gram-negative pathogens Read More